| C1QL1 High (N=267) |
C1QL1 Low (N=268) |
P-value | |
|---|---|---|---|
| sex | |||
| FEMALE | 80 (30.0%) | 106 (39.6%) | 0.0252 |
| MALE | 187 (70.0%) | 162 (60.4%) | |
| age | |||
| older | 143 (53.6%) | 125 (46.6%) | 0.13 |
| younger | 124 (46.4%) | 143 (53.4%) | |
| stage | |||
| I/II | 133 (49.8%) | 196 (73.1%) | <0.001 |
| III/IV | 134 (50.2%) | 72 (26.9%) | |
| grade | |||
| G1 | 2 (0.7%) | 12 (4.5%) | <0.001 |
| G2 | 93 (34.8%) | 138 (51.5%) | |
| G3 | 117 (43.8%) | 92 (34.3%) | |
| G4 | 54 (20.2%) | 21 (7.8%) | |
| GX | 1 (0.4%) | 5 (1.9%) | |
| T | |||
| T1/2 | 144 (53.9%) | 201 (75.0%) | <0.001 |
| T3/4 | 123 (46.1%) | 67 (25.0%) | |
| N | |||
| N0 | 111 (41.6%) | 129 (48.1%) | 0.133 |
| N1 | 11 (4.1%) | 5 (1.9%) | |
| NX | 145 (54.3%) | 134 (50.0%) | |
| M | |||
| M0 | 204 (76.4%) | 220 (82.1%) | <0.001 |
| M1 | 54 (20.2%) | 24 (9.0%) | |
| MX | 9 (3.4%) | 24 (9.0%) | |
| pharmaceutical | |||
| NO | 221 (82.8%) | 239 (89.2%) | 0.0444 |
| YES | 46 (17.2%) | 29 (10.8%) | |
| smoking | |||
| less | 157 (58.8%) | 144 (53.7%) | 0.274 |
| more | 110 (41.2%) | 124 (46.3%) | |
| Event | |||
| 0 | 164 (61.4%) | 198 (73.9%) | 0.00281 |
| 1 | 103 (38.6%) | 70 (26.1%) |